T Rowe PR Health Science-InvPRHSX
13F holders, Q4 2025 (December 31)4holders −1
0new positions
1sold out
$83.55avg. 13F price*
At the end of Q4 2025, 4 institutions reported holding T Rowe PR Health Science-Inv (PRHSX) in their 13F filings, down 1 from Q3 2025. 0 opened new positions and 1 sold out. The largest holders were Ethos Financial Group, LLC ($204K), Westside Investment Management, Inc. ($123K) and Coston, McIsaac & Partners ($66K).
- Company
- T Rowe PR Health Science-Inv
- CUSIP
- 741480107
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 1 | $237K |
All 13F filers, Q3 2025 → Q4 2025: 97 shares bought and 2,997 shares sold, net −2,900 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 4 holders
| Ethos Financial Group, LLC | 0.02% | Reduce -3.1% | 2,438 | $204K |
| Westside Investment Management, Inc. | 0.02% | No change | 1,467 | $123K |
| Coston, McIsaac & Partners | 0.02% | Add +11.9% | 790 | $66K |
| Financial Gravity Asset Management, Inc. | 0.00% | Add +11.9% | 122 | $10K |
"% of holder's portfolio" is PRHSX's weight in each manager's 13F, not the share of T Rowe PR Health Science-Inv the manager owns.